Metformin is a widely prescribed, low-cost generic medication, making it more accessible than newer treatments such as GLP1 receptor agonists or SGLT2 inhibitors71, and carries a lower risk of hypoglycemia than agents like insulin or sulfonylureas72, 73. This evidence concerns the gene INS and Hypoglycemia.